Tanshinone I Exerts Cardiovascular Protective Effects in Vivo and in Vitro Through Inhibiting Necroptosis via Akt/nrf2 Signaling Pathway

doi:10.21203/rs.3.rs-381824/v1

Download PDF

Research

Tanshinone I Exerts Cardiovascular Protective Effects in Vivo and in Vitro Through Inhibiting Necroptosis via Akt/nrf2 Signaling Pathway

https://doi.org/10.21203/rs.3.rs-381824/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background

Tanshinone I (TI) is a primary component of Salvia miltiorrhiza Bunge (Danshen), which confers a favorable role in a variety of pharmacological activities including cardiovascular protection. However, the exact mechanism of the cardiovascular protection activity of TI remains to be illustrated. In this study, the cardiovascular protective effect and its mechanism of TI were investigated.

Methods

In this study, tert-butyl hydroperoxide (t-BHP)-stimulated H9c2 cells model was employed to investigate the protective effect in vitro. The cell viability was determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay and lactate dehydrogenase (LDH) kit. The reactive-oxygen-species (ROS) level and mitochondrial membrane potential (MMP) were investigated by the flow cytometry and JC-1 assay, respectively. While in vivo experiment, the cardiovascular protective effect of TI was determined by using myocardial ischemia-reperfusion (MI/R) model including hematoxylin-eosin (H&E) staining assay and determination of superoxide dismutase (SOD) and malondialdehyde (MDA). Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) release were detected by Enzyme-linked immunosorbent assay (ELISA). All related protein expression was determined by western blotting.

Results

Our data demonstrated that TI pretreatment attenuated t-BHP- and MI/R injury-induced necroptosis by inhibiting the expression of p-RIP1, p-RIP3, and p-MLKL. TI activated the Akt/Nrf2 pathway to promote the expression of antioxidant-related proteins such as phosphorylation of Akt, nuclear factor erythroid 2 related factor 2 (Nrf2), quinone oxidoreductase-1 (NQO-1) and heme oxygenase-1 (HO-1) expression in t-BHP-stimulated H9c2 cells. TI relieved oxidative stress by mitigating ROS generation and reversing MMP loss. In vivo experiment, TI made electrocardiograph (ECG) recovery better and lessened the degree of myocardial tissue damage. The counts of white blood cell (WBC), neutrophil (Neu), lymphocyte (Lym), and the release of TNF-α and IL-6 were reversed by TI treatment. SOD level was increased, while MDA level was decreased by TI treatment.

Conclusion

Collectively, our findings indicated that TI exerted cardiovascular protective activities in vitro and in vivo through suppressing RIP1/RIP3/MLKL and activating Akt/Nrf2 signaling pathways, which could be developed into a cardiovascular protective agent.

Clinical Pharmacology

Tanshinone I

oxidative stress

necroptosis

myocardial ischemia reperfusion

RIP1/RIP3/MLKL

Akt/Nrf2

The incidence and mortality of cardiovascular diseases have been increasing in recent years [1], and myocardial ischemia represents a major contributor to cardiovascular diseases [2]. Myocardial ischemia refers to the gradual decrease in blood perfusion to the heart, resulting in a reduction in oxygen supply to the heart and insufficient energy metabolism of the heart muscle, which cannot guarantee the normal and regular work of the heart [3]. At present, the main therapeutic strategy is to restore the blood supply to the myocardial ischemia site in multiple ways. However, MI/R, one of the most representative models, will also bring about a series of metabolic disorders, dysfunction, and structural destruction of tissues and organs, such as arrhythmias, enlarged infarcted area, ventricular dysfunction, and energy metabolism disorders, and other additional reperfusion damage [4, 5].

MI/R injury is the key to poor prognosis of patients [5]. The onset of this damage is related to calcium overload, inflammatory response, energy metabolism disorder and oxygen-free radicals. And it can cause damage to the myocardium [4, 6], promote the occurrence of myocardial remodeling, increase myocardial infarction area and facilitate the release of various inflammatory factors [7, 8] and antioxidant free radicals [9]. Among them, the production of oxygen free radicals is closely related to MI/R injury. In patients with myocardial ischemia, the content of free radical scavenging agents will be reduced [10], leading to the rise of free radicals, which not only motivates cell damage but also accelerates cell death [11]. Accordingly, in the treatment of patients, effective scavenging of oxygen free radicals and cardiomyocytes’ damage can be reduced by inhibition of the generation of oxygen free radicals.

Necroptosis, a form of necrosis, can be controlled, in which dead cells rupture and liberate components inside the cells incurring cell death. In contrast to apoptosis, necroptosis leads to fracture of the plasma membrane, thus cell contents overflow, bringing about inflammation and the immune system is triggered. Necroptosis signals need the involvement of RIP1, RIP3, and MLKL kinase. There is growing literature that programmed necroptosis occupies a crucial part in MI/R [12]. Therefore, suppression of necroptosis is an alternative strategy for the treatment of cardiovascular diseases [13].

A previous study indicated that ROS always leads to cells necroptosis. Akt/Nrf2 pathway is crucial to modulate ROS generation [14]. Akt participates in the positive regulation of Nrf2 antioxidant. Then Nrf2 activated further separates from Keap1, entering into the nucleus to form dimers with Maf, recognizing and binding to the binding sites on ARE which will induce the transcription of NQO-1 as well as HO-1 to reduce oxidative stress injury [14, 15]. Accordingly, the regulation of Akt/Nrf2 signaling pathway to reduce ROS generation-induced necroptosis will be an effective therapeutic strategy for the treatment of cardiovascular diseases.

Salvia miltiorrhiza Bunge (Danshen) is a traditional Chinese medicine that has widely incorporated into therapy to cardiovascular diseases through invigorating blood circulation and dispersing blood stasis [16]. Tanshinone I (TI) (Fig. 1a), a fat-soluble compound, is a major ingredient in Danshen [17]. However, the mechanism of cardiovascular protection of TI has not been revealed. In this study, using t-BHP-stimulated H9c2 cells and MI/R SD rat model, we investigated TI’s cardiovascular protective effect and mechanism in vitro and in vivo.

Chemical and Reagents.

Tanshinone I was purchased from Chengdu Pufei De Biotech Co., Ltd, (Chengdu, China), while its purity (over 98%) was measured by HPLC. Verapamil hydrochloride was selected and bought from a Shanghai Macklin Biochemical Technology Co., Ltd, (Shanghai, China). 2′, 7′-Dichlorodihydrofluorescein diacetate (DCFH₂-DA), t-BHP, Dimethyl sulfoxide (DMSO), MTT and Necrostatin-1 (Nec-1) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Double staining kit (7-AAD & Annexin V-PE) was bought from BD Pharmingen^TM (Becton-Dickinson, NJ, USA). From Life Technologies/Gibco Laboratories (Grand Island, NY, USA), fetal bovine serum (FBS), as well as dulbecco’s modified eagle medium (DMEM) were bought. JC-1 kit and LDH assay kit were obtained from Beyotime (Shanghai, China). From Thermo Fisher Scientific (Waltham, MA, USA), BCA protein detection kit was obtained. ELISA kits from Neobioscience (Shenzhen, China). MDA, as well as SOD detection kits, were purchased on selection from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Antibodies: p-RIP1 (AF7088), p-RIP3 (AF7443), p-MLKL (AF7420), RIP1(AF7877), and RIP3(AF7942) were purchased from Affinity Biosciences (Cincinnati, OH, USA), GAPDH (#5174), p-Akt (#4060), Akt (#4691), HO-1 (#70081), and secondary antibodies from Cell Signaling Technology (Beverly, MA, USA). MLKL (ab196436), Nrf2 (ab31163) and NQO1 (ab80588) were acquired from Abcam (Cambs, UK).

Cell culture

H9c2 cells, purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China), were placed in DMEM medium (10% FBS and 1% Penicillin/Streptomycin) for cultivation in an incubator with a specified temperature of 37°C and a humidity of 5%.

Cell viability assay

4.0×10³ cells per well were cultured in 96-well plates overnight, which were treated with TI (0.125, 0.25, 0.5, 1, and 2 μM), Nec-1 (20, 40, 80, and 100 μM) or t-BHP (50, 100, and 150 μM) for 12 h, 12 h and 10 h subsequently. Our study employed MTT to detect the viability of cells and monitored the absorbance with a microplate reader (BioTek, Winkowski, VT, USA) at a wavelength of 570 nm.

Double staining assay

H9c2 cells were cultured in 6-well plates (1.5 ×10⁵ cells per well). Afterwards, H9c2 cells were pretreated with TI (1 μM) for 2 h and treated with t-BHP (150 μM) for 6 h. After collection, cells were stained with Annexin V-PE/7-AAD and were detected by flow cytometry (Becton-Dickinson, NJ, USA).

Measurement of lactate dehydrogenase (LDH) Release

Inoculated on 96-well plates (4×10³ per well) overnight and pretreated with TI (0.25, 0.5, and 1 μM) for 2 h, H9c2 cells were co-cultured with t-BHP (150 μM) for 10 h. Medium was collected to measure LDH level as per the manufacturer’s instruction of LDH. Using a microplate reader (490 nm wavelength), the absorbance was determined.

Intracellular reactive oxygen species (ROS) detection

H9c2 cells were seeded into 12-well plates (7.0×10⁴ cells per well) overnight and treated with t-BHP (150 μM) for a different time, respectively, which subsequently were co-cultured with TI (0.25, 0.5, and 1 μM) for 2 h. Then cells were labeled with DCFH₂-DA (1 μM, 0.5 h), which were monitored by flow cytometry at the FITC channel. The images were captured by a fluorescence microscope (Leica, Wetzlar, Germany) [18].

Mitochondrial membrane potential (MMP)’s detection assay

Based on our anterior study [19], cells were cultured in 96-well plates (4.0×10³ cells in each well) overnight. After that, the cells were exposed to TI (1 μM) for 2 h and cultured with t-BHP (150 μM) up to 4 h. For measuring the MMP, JC-1 (5 µg/mL) was co-cultured for 30 min and relevant images were captured by a fluorescence microscope.

Animal experiments and ethical statement

The study was authorized by the Experimental Animal Management Ethics Committee of Guangxi University of Traditional Chinese Medicine (Approval Document No. SYXK-GUI-2019-0001). As per the “Guidelines for the Care and Use of Laboratory Animals in Guangxi University of Traditional Chinese Medicine”, all animals have received humane care. Healthy SD rats (male, 220–250 g) were purchased from Hunan Saike Jingda Experimental Animal Co. Ltd (Changsha, China) and acclimated for one week. Under normative SPF (specific pathogen-free) circumstances, all animals were housed and had free access to water as well as food with a befitting and controllable humidity (50%) and temperature (25℃).

Conventionally, the animals were divided into the sham-operated group, MI/R group, TI-L group (10 mg/kg), TI-H group (20 mg/kg), and positive drug Verapamil hydrochloride (Ver) group (20 mg/kg) at random and each group consisted of 15 rats. The rats were given pre-administration for one week before modeling. The rats were intraperitoneally injected with TI once a day while the sham operation group and MI/R group were given the uniform amount of normal saline at the corresponding time.

Construction of MI/R SD rat model

The MI/R rats were operated by transient myocardial ischemia for 0.5 h and reperfusion for 2 h therewith. In short, the experimental rats were narcotized by intraperitoneal injection of 10% chloral hydrate (4 mL/kg). These rats were concatenated to a rodent ventilator (respiratory rate of 58-70 breaths/min, respiratory ratio of 5:4, tidal volume of 6-7 mL/time). The third and fourth ribs were cut open, leaving the heart nearly entirely exposed. Then 6-0 silk suture was used to ligature LAD (the left anterior descending coronary artery) at the distal 1/3. The heart grew grey promptly [20]. The ligation was disentangled after occlusion for 30 min, the heart going through reperfusion for 2 h. The sham-operated group underwent the identical operation and was penetrated in absence of ligation. ECG changes were recorded throughout the whole experiment by BL-420N biological signal acquisition and analysis system (Chengdu, China).

Histopathology examination

Fixed with 4% paraformaldehyde and dehydrated with alcohol gradient, the heart tissue samples were then processed with xylene transparently and paraffin-embedded. Hematoxylin and eosin (H&E) staining were employed after the samples were sectioned. Ultimately, with an optical microscope (UOP, DSZ5000X, China), the study observed the pathological changes of the tissue.

Hematology analysis

Blood was collected from the abdominal aorta of rats. WBC, Neu, and Lym count from blood were determined by an auto hematology analyzer (Mindray, Shenzhen, China).

Determination of SOD, MDA, TNF-α, IL-6

With a tissue grinder (Tianjin, China), SD rats’ heart tissue was homogenized. The samples were centrifuged. Their supernatant was collected immediately and stored at -80°C. As per the manufacturer’s instructions, the SOD, MDA examined by corresponding kits, TNF-α and IL-6 levels were detected by ELISA kits.

Western blotting analysis.

H9c2 cells were seeded into a dish overnight. TI (0.25, 0.5, and 1 μM) was pretreated for 2 h and co-cultured with t-BHP induction for 4 h. For animal experiments, heart tissue was collected to investigate the related protein expression. The study employed RIPA (1% PMSF and 1% cocktail) to extract total proteins of cells as well as the heart tissue. As per the manufacturer’s instruction, the concentration of the protein was measured by the BCA protein kit. Through 10% or 12% SDS-PAGE gels, the denatured protein was separated, which was transferred to polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, USA). After 5% skim milk blocking the PVDF membrane up to 2 h, incubate the membrane with 1:1000 primary antibodies at 4°C for over 12 h. The membrane was exposed to ChemiDoc™ MP Imaging System (Bio-Rad, Hercules, CA, USA) after washing with TBST and incubating with secondary antibody (1:5000) for 2 h at room temperature, of which GAPDH was the specified house-keeping protein.

Statistical analysis.

Dates were presented as means ± SD. All experiments were repeated at least three times. Dates were normally distributed and GraphPad Prism 6.0 software was used to perform one-way-ANOVA or Student’s t-test. When p < 0.05, results were considered to be statistically significant.

TI exerted protective effects on t-BHP-stimulated H9c2 cells.

The cytotoxicity of TI was detected by the MTT method. The results indicated that TI (0.125, 0.25, 0.5, 1, and 2 μM) displayed no significant toxicity in H9c2 cells as exhibited in Fig. 1b. In contrast with the control group, t-BHP (100, 150, and 200 μM) reduced cell viability to a diverse degree. t-BHP (150 μM) was selected as the befitting and conclusive concentration to conduct the following experiments (Fig. 1c). TI pretreatment could rescue t-BHP-stimulated cell death. (Fig. 1d). In addition, TI reversed t-BHP-induced LDH release in H9c2 cells (Fig. 1e). Simultaneously, the double staining results indicated that TI significantly decreased t-BHP-induced cell death (Figs. 1f-g). All in all, these results indicated that TI exerted protective effects on t-BHP-stimulated H9c2 cells.

TI ameliorated t-BHP-induced cell necroptosis via RIP1/RIP3/MLKL pathway. As shown in Fig. 2a, Nec-1 (20-100 μM), the necroptosis inhibitor, had no cytotoxicity in H9c2 cells. Nec-1 could prominently inhibit t-BHP-stimulated H9c2 cells necroptosis, particularly the 100 μM (Fig. 2b). Like the effect of Nec-1, TI significantly inhibited t-BHP-induced necroptosis (Fig. 2c), of which the effects were further confirmed by the LDH results (Fig. 2d). Microscopic images also comfimed this results (Fig. S1). In addition, necroptosis was primarily mediated by the RIP1/RIP3/MLKL signaling pathway [21]. Compared with the control group, t-BHP augmented phosphorylation of RIP1, RIP3, and MLKL, of which TI could reverse these effects (Figs. 2e-h). Collectively, TI reversed t-BHP-induced necroptosis in H9c2 cells.

TI mitigated t-BHP-induced ROS generation in H9c2 cells.

A sharp augment of ROS level can be stimulated by t-BHP, in the meantime, promoting oxidative stress [22]. The intracellular ROS generation was monitored by immunofluorescent assay and flow cytometry assay. As shown in Figs. 3a-b, t-BHP could augment the ROS level when H9c2 cells were irritated by t-BHP for 4 h. As shown in Figs. 3c-d, TI observably suppressed t-BHP-induced ROS generation in H9c2 cells. In addition, fluorescence microscopy was applied to the observation of ROS production. Results exhibited that TI (1 μM) reduced t-BHP-induced fluorescence intensity dramatically (Fig. 3e), which corresponded to the above results. To sum up, our results revealed that ROS level was lowered by TI, suggesting that TI owned the advantage of anti-oxidative activity.

TI reversed t-BHP-induced mitochondrial-membrane-potential (MMP) loss.

t-BHP destroyed the stability of MMP, which was to the disadvantage of keeping normal physiological functions of cells [23]. The changes in MMP were observed by a fluorescence microscope. Results exhibited that under normal circumstances, JC-1 existed in the form of polymer in the cell mitochondria with vivid red fluorescence, and the MMP reduced after cells were treated with t-BHP, which JC-1 couldn’t be present in the mitochondrial matrix as a polymer [24]. Under this circumstance, the red fluorescence’s intensity was markedly decreased, while in the cytoplasm the green fluorescence was signally stronger. This situation was reversed dramatically when the cells were pretreated with TI (1 μM). Collectively, TI (1 μM) rescued t-BHP-stimulated MMP loss (Fig. 4a).

TI activated Akt/Nrf2 signaling pathway to relieve oxidative stress injury.

Activation of Akt/Nrf2 signaling pathway occupies a crucial part in the process of anti-oxidative stress [25]. As depicted in Figs. 5a-b, t-BHP lead to the higher expression levels of p-Akt, while TI promoted this effect obviously without altering the Akt. Nrf2, one of the significant nuclear transcription factors, regulates constitutive and inducible expression of anti-oxidant and phase 2 detoxification enzymes coordinately, such as NQO-1 and HO-1 [25, 26]. In the present study, TI markedly increased Nrf2, HO-1, and NQO-1 protein expression. (Figs. 5c-f). In summary, our results demonstrated that TI improved the expression of anti-oxidative-enzyme-related proteins after t-BHP challenge to relieve oxidative stress injury.

TI pretreatment improved cardiac function and alleviated MI/R injury in SD rats.

Cardiac function of rats after MI/R injury was detected by ECG. As indicated in Fig. 6a, under normal conditions, TI-treated rats showed no significant difference compared to that of the sham group, suggesting that TI showed no cardiotoxicity. The ST segment of all rats was observably elevated after ischemia, but gradually lowering after reperfusion. Besides, compared with the MI/R group, TI-treatment group and Ver-treatment group’s ECG recovered better after 2 h reperfusion. The H&E staining results revealed that the degree of myocardial tissue damage during MI/R in rats. The myocytes of the sham operation group were normal without bleeding or neutrophil infiltration. Myocardial injury was severe in the ischemic area after MI/R. Myocardial fibers dissolved and infiltrated inflammatory cells. After MI/R, neutrophils congregated in ischemic areas of the heart. TI and Ver treatment alleviated MI/R-induced myocardial injury (Fig. 6b). TI pre-treatment decreased MDA level aggrandized by MI/R in myocardial tissue (Fig. 6c). On the contrary, the level of SOD was reduced by MI/R, but when TI pre-treatment, this change was reversed. (Fig. 6d).

TI restored MI/R-induced imbalance of blood parameters and inhibited inflammatory cytokines release.

The blood amount of WBC, Neu, and Lym is commonly used as inflammation biomarkers [27]. When SD rats encountered MI/R, it caused inflammation. Contrasted with the sham group, the blood counts of WBC (Fig. 7a), Neu (Fig. 7b), and Lym (Fig. 7c) were substantially increased in the MI/R group. However, TI suppressed the abnormal rise of WBC, Neu, as well as Lym, of which its effects amounted to that of the positive drug, Verapamil. Besides, we detected the production of inflammatory cytokines of heart tissue. The cytokines like TNF-α and IL-6 levels were augmented after MI/R. In contrast, TI (20 mg/kg) could down-regulate IL-6 and TNF-α levels (Figs. 7d-e).

TI pretreatment lightened myocardial necroptosis to ameliorate MI/R injury.

The previous study indicated that MI/R injury always led to necroptosis in heart tissues [13]. In our study, using the heart tissues, we found that TI ameliorated MI/R-induced necroptosis. As shown in Fig. 8, TI reversed MI/R-induced the phosphorylation of RIP1, RIP3, and MLKL protein expression.

Cardiovascular disease with high morbidity and mortality is a severe threat to human health [28]. There is increasing evidence that Danshen’s components can prevent cardiovascular diseases, especially atherosclerosis and heart diseases, including myocardial infarction, MI/R injury, arrhythmias, cardiac hypertrophy, and myocardial fibrosis. TI, one of the main fat-soluble components of Danshen, has been used to treat cardiovascular and inflammatory diseases. TI has a protective effect on ischemic injury and can inhibit the proliferation of vascular smooth muscle cells [29, 30]. It also has significant anti-inflammatory activity against both carrageenan-induced foot swelling and adjuvant-induced arthritis [31-34]. In this study, we chiefly focused on the cardiovascular protective effects of TI in vitro and in vivo.

The imbalance of cell death promotes the pathogenesis of cardiovascular diseases and is a clinical target therapy in the course of disease occurrence [12, 35]. Necrosis, previously considered as an unregulated form of cell death, has been recognized as a highly regulated process up to now and has attracted widespread attention in the past decade [36, 37]. In addition, necroptosis, a kind of programmed necrosis, would be exacerbated in t-BHP-induced endothelial cells [23]. Recent evidence showed that a significant increase in intracellular ROS results in cell necroptosis [38, 39]. ROS is involved in TNF-induced necroptosis of human colon adenocarcinoma HT-29 cells [38]. t-BHP, a better alternative for unstable H₂O₂, is an organic peroxide broadly used in multiple oxidative stress studies and can liberate ROS, resulting in oxidative stress injury [40]. Whereas still much less is known about the contribution of t-BHP- stimulated oxidative stress injury and necroptosis in H9c2 cells. Furthermore, it has been reported that enhanced Akt phosphorylation promotes cardiac myocyte survival [14, 41]. And Nrf2 is normally deemed to be a key transcription factor in anti-oxidative stress by strengthening antioxidant genes’ expression such as HO-1 and NQO-1. In this study, we found that TI could conspicuously decrease ROS generation (Figs. 3a-e) and relieve oxidative stress injury through activating Akt/Nrf2 signaling pathways, promoting the phosphorylation of Akt, and the expression of anti-oxidative-enzyme-related proteins, namely Nrf2, NQO-1 and HO-1(Figs. 5a-f). Even superfluous ROS impacted mitochondria performance by decreasing MMP negatively [42], which was mitigated by TI (1 μM) (Fig. 4a).

Myocardial ischemia-reperfusion (MI/R) injury is an urgent problem in clinical treatment [43]. MI/R injury irreversibly damage the structure and function of the heart [4]. With the in-depth study on the anti-MI/R injury efficacy of traditional Chinese medicine, it has been confirmed that it can alleviate MI/R injury by regulating programmed necrosis [44, 45]. TNFR1-induced necroptosis is incurred by a signaling cascade referring to special serine-threonine proteins RIP1, RIP3, and MLKL [46, 47]. Nevertheless, potential therapeutic reagents, such as Nec-1 inhibitor, could offer protection from the adverse effects of necroptosis [48]. Hence, our study focused on the relation between MI/R and necroptosis. Gratifyingly, TI conferred a favorable role in the improvement of MI/R injury via restraining p-RIP1, p-RIP3, and p-MLKL expression.（Figs. 8a-d）.

Under physiological conditions, ROS acts as a second messenger to regulate a variety of signaling pathways [49]. Nonetheless, excess intracellular ROS leads to damage to the molecular components of cells, contributing to a wide variety of pathogenesis human diseases. A large number of studies have shown that ROS production is closely related to the process of cell death and promotes the occurrence of cell death as well as the development of cardiovascular diseases. Studies have shown that when myocardial ischemia, blood recovers after hypoxia, and oxygen supply will produce overmuch ROS, which will culminate in oxidative stress in the myocardium induced MI/R injury [50]. Electron paramagnetic resonance (EPR) was employed to directly measure myocardial free radicals and it was found that a large amount of ROS was produced immediately after MI/R, which lasted for tens of minutes [51]. Fortunately, SOD is the main antioxidant enzyme that removes oxidative free radicals in the body, and its activity can reflect the ability to reduce oxidative free radicals. When ROS reacts with a polyunsaturated fatty acid, its lipid peroxide products, such as MDA, can reflect its lipid peroxide damage and indirectly indicate the injury of ROS to the body [52, 53]. Our research elucidated that the level of MDA in heart tissue was aggrandized by MI/R and TI pre-treatment observably decrease this effect (Fig 6c). Oppositely, the level of SOD was reduced by MI/R and this effect was reversed by TI pre-treatment (Fig. 6d), which manifested the anti-oxidative properties of TI.

Of note, not only does the generation of ROS mediate the above aspects, but also it promotes inflammatory response [54]. TNF-α is a crucial pro-inflammatory cytokine, which exerts key effects in the synthesis and release of inflammatory mediators, complement activation, and other physiological responses [38]. A pivotal cytokine, IL-6, is produced by fibroblasts as well as T cells, which are in a state of activation, and occupy comprehensive biological activities, for instance, immune regulation [55, 56]. Accumulating evidence has indicated that not only can IL-6 catalyze inflammatory response, but also it can amplify it. Its level of expression is able to reflect the seriousness of tissue cell injury effectually, and IL-6 can be utilized as a valid index for chronic as well as acute inflammation in terms of clinical diagnosis [57]. Our study showed that TI could prevent myocardial fibers dissolved and infiltrated inflammatory cells (Fig. 6b). TI lowered the amount of WBC, Neu and Lym in blood of rats encountering MI/R (Figs. 7a-c). Besides, TI exerted significant inhibitory effects on TNF-α and IL-6 (Figs. 7d-e). Therefore, TI owned a prominently protective effect on assuaging MI/R injury.

To sum up, our data indicated that TI could relieve t-BHP-stimulated oxidative stress injury by suppressing RIP1/RIP3/MLKL and activating Akt/Nrf2 signaling pathways (As shown in Fig. 9). Also, TI could improve cardiac function in response to MI/R injury by regulation of RIP1/RIP3/MLKL signaling pathway. These underlying mechanisms of TI highlighted that TI owned the advantage of promising cardiovascular protection activities, which facilitated the development of a novel agent for the treatment of cardiovascular diseases.

TI: Tanshinone I; t-BHP: tert-butylhydroperoxide; Ver: Verapamil hydrochloride; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; LDH: lactate dehydrogenase; ROS: reactive-oxygen-species; MMP: mitochondrial membrane potential; MI/R: myocardial ischemia-reperfusion; H&E: hematoxylin-eosin; SOD: superoxide dismutase; MDA: malondialdehyde; TNF-α: tumor necrosis factor-α; IL-6: Interleukin-6; RIP1: receptor interacting protein kinase 1; RIP3: receptor interacting protein kinase 3; MLKL: mixed lineage kinase domain-like protein; WBC: white blood cell; Neu: neutrophils; Lym: lymphocyte; DMEM: Dulbecco’s modified eagle medium; DMSO: Dimethylsulfoxide; ELISA: Enzyme-linked immunosorbent assay; FBS: Fetal bovine serum; Nrf2: Nuclear factor erythroid 2 related factor 2; HO-1: Heme oxygenase-1; NQO-1: NAD(P)H: quinone oxidoreductase-1; PVDF: polyvinylidene fluoride; ECG: Electrocardiograph; EPR: Electron paramagnetic resonance; LAD: left anterior descending coronary artery.

Ethics approval and consent to participate

The study was established according to the ethical guidelines and approved by the Ethics Committee on Laboratory Animal Management of Guangxi University of Chinese Medicine.

Consent for publication

We declare that the Publisher has the Author’s permission to publish the relevant contribution.

Availability of data and materials

Not applicable.

Competing interests

The authors declare no competing conflict of interests.

Funding

We would like to appreciate the support from Guangxi Science and Technology Base and Talent Special Project (2018AD19034), the Project of Guangxi Innovation-driven Development (2019AA17002), Guangxi Key Research and Development Plan (2020AB39014), the National Natural Science Foundation of China (NSFC, 81803807, 81860711, China), Guangxi Natural Science Foundation (2018JJB140265, 2018JJB140263), Qihuang High-level Talent Team Cultivation Project of Guangxi University of Chinese Medicine (2021002), and the Project of Guangxi Overseas “100 persons plan” High-level Expert.

Authors’ contributions

HG, SY, and RY designed the research. YZ, XC, and JH conducted the experiments. YZ and HG wrote the manuscript. RY, YC, CZ, KS and ZL revised the manuscript. All authors read and approved the final manuscript.

Acknowledgments

We would like to appreciate the technological support from Qiongming Xu (Soochow University) and Liba Xu (Guangxi University of Chinese Medicine).

A G, B G, Fuster CV. The Global Burden of Cardiovascular Diseases and RiskFactors. Journal of the American College of Cardiology. 2019; 74(20): 2529-2532.
Massimo, Fioranelli, Anna, Bottaccioli, Francesco, Maria, Bianchi, Miriam, Rovesti. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based. Frontiers in Immunology. 2018; 9: 1-15.
Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Failure Reviews. 2019; 25(1): 53-65.
Heusch G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nature Reviews Cardiology. 2020; 17(12): 1-17.
Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nature Reviews Cardiology. 2016; 13(4): 193-209.
Mokhtari-Zaer A, Marefati N, Atkin SL, Butler AE, Sahebkar A. The protective role of curcumin in myocardial ischemia–reperfusion injury. Journal of cellular physiology. 2019; 234(1): 214-222.
Huilin, Hu, Changlin, Zhai, Gang, Qian, Aiming, Gu, Jialiang, Liu. Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction. Pharmaceutical Biology. 2015; 53(12): 1752-1758.
Stefano T, Mauro AG, S CZ, Antonio A. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. AJP Heart and Circulatory Physiology. 2018; 315(6): H1553-H1568.
Schanze N, Bode C, Duerschmied D. Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. Frontiers in Immunology. 2019; 10: 1-9.
Ming-Shuo S, Hang J, Xin S, Shuo H, Fu-Liang Z, Zhen-Ni G, Yi Y. Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy. Oxidative Medicine and Cellular Longevity,2018,(2018-1-31). 2018; 2018: 1-17.
Cadenas, Susana. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radical Biology & Medicine. 2018; 117: 76-89.
Zhu H, Sun A. Programmed necrosis in heart disease: Molecular mechanisms and clinical implications. Journal of Molecular & Cellular Cardiology. 2018; 116: 125-134.
Zhou W, Yuan J. Necroptosis in health and diseases. Seminars in Cell & Developmental Biology. 2014; 35: 14-23.
Wen Z, Hou W, Wu W, Zhao Y, Song L. 6'- O -Galloylpaeoniflorin Attenuates Cerebral Ischemia Reperfusion-Induced Neuroinflammation and Oxidative Stress via PI3K/Akt/Nrf2 Activation. Oxidative Medicine and Cellular Longevity,2018,(2018-3-25). 2018; 2018: 1-14.
Hsieh YH, Deng JS, Yuan-Shiun C, Huang GJ. Ginsenoside Rh2 Ameliorates Lipopolysaccharide Induced Acute Lung Injury by Regulating the TLR4/ PI3K/Akt/mTOR, Raf-1/MEK/ERK and Keap1/Nrf2/HO-1 Signaling Pathways in Mice. Nutrients. 2018; 10(9): 1-17.
Ren J, Fu L, Nile SH, Zhang J, Kai G. Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications. Frontiers in Immunology. 2019; 10: 1-15.
Liao P, Hemmerlin A, Bach TJ, Chye ML. The potential of the mevalonate pathway for enhanced isoprenoid production. Biotechnology advances. 2016; 34(5): 697-713.
Renyikun, Yuan, Liting, Huang, Li-Jun, Du, Jian-Fang, Feng, Jun, Li. Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization. Pharmacological Research. 2019; 142: 102-114.
Hongwei, Gao, Yankun, Cui, Naixin, Kang, Xin, Liu, Yanli, Yue. Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization. British Journal of Pharmacology. 2017; 174(17): 2880-2896.
Yeghiazarians Y, Stone PH. ST-segment elevation myocardial infarction. Curr Treat Options Cardiovasc Med. 2002; 4(1): 3-23.
Shi ZW, Ge LS, Li YC. The Role of Necroptosis in Cardiovascular Disease. Frontiers in Pharmacology. 2018; 9: 1-9.
Ghosh M, Manna P, Sil PC. Protective role of a coumarin-derived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs, NF-κκB and mitochondria-dependent pathways. Free Radical Research. 2011; 45(5): 620-637.
Zhao W, Feng H, Sun W, Liu K, Lu JJ, Chen X. Tert-butyl hydroperoxide (t-BHP) induced apoptosis and necroptosis in endothelial cells: Roles of NOX4 and mitochondrion. Redox Biology. 2017; 11: 524-534.
Han S, Gao H, Chen S, Wang Q, Li X, Du LJ, Li J, Luo YY, Li JX, Zhao LC. Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells. Scientific Reports. 2019; 9(1): 1-13.
Ali T, Kim T, Rehman SU, Khan MS, Amin FU, Khan M, Ikram M, Kim MO. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease. Molecular Neurobiology. 2017; 55(7): 6076-6093.
Li ST, Dai Q, Zhang SX, Liu YJ, Yu QQ, Tan F, Lu SH, Wang Q, Chen JW, Huang HQ. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacologica Sinica. 2018; 39(8): 1294-1304.
He J, Yuan R, Cui X, Cui Y, Gao H. Anemoside B4 protects against Klebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice. Chinese Medicine. 2020; 15(1): 1-13.
England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. Bmj. 2018; 361: 1-17.
Wu YT, Bi YM, Tan ZB, Xie LP, Xu HL, Fan HJ, Chen HM, Li J, Liu B, Zhou YC. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway. European Journal of Pharmacology. 2019; 853: 93-102.
Dai C, Liu Y, Don Z. Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage. Molecular Brain. 2017; 10(1): 1-11.
Cui S, Chen S, Wu Q, Chen T, Li S. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. International Immunopharmacology. 2020; 81: 1-9.
Wang X, Fan J, Ding X, Sun Y, Cui Z, Liu W. Tanshinone I Inhibits IL-1β-Induced Apoptosis, Inflammation And Extracellular Matrix Degradation In Chondrocytes CHON-001 Cells And Attenuates Murine Osteoarthritis. Drug Design Development & Therapy. 2019; 13: 3559-3568.
Wang S, Jing H, Yang H, Liu Z, Guo H, Chai L, Hu L. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Journal of Ethnopharmacology. 2015; 164: 247-255.
Kim SY, Moon TC, Chang HW, Son KH, Kim HP. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. Phytotherapy Research. 2010; 16(7): 616-620.
Adameova A, Goncalvesova E, Szobi A, Dhalla NS. Necroptotic cell death in failing heart: relevance and proposed mechanisms. Heart Failure Reviews. 2016; 21(2): 213-221.
Bai Y, Lam HC, Lei X. Dissecting Programmed Cell Death with Small Molecules. Accounts of Chemical Research. 2020; 53(5): 1034-1045.
Lockshin RA, Williams CM. Programmed cell death—I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. Journal of Insect Physiology. 1965; 11(2): 123-133.
Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proceedings of the National Academy of Sciences. 2012; 109(14): 5322-5327.
Gao X, Zhang H, Zhuang W, Yuan G, Dong H. PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Scientific Reports. 2014; 4: 1-7.
Terluk MR, Ebeling MC, Fisher CR, Kapphahn RJ, Ferrington DA. N-Acetyl-L-cysteine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage: Implications for Age-Related Macular Degeneration. Oxidative medicine and cellular longevity. 2019; 2019(3): 1-14.
Wang Z, Wang Y, Ye J, Lu X, Cheng Y, Xiang L, Chen L, Feng W, Shi H, Yu X. bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion viaactivation of PI3K/Akt/ERK1/2 pathway. Journal of Cellular & Molecular Medicine. 2015; 19(3): 595-607.
Wang QQ, Gao H, Yuan R, Han S, Yang S. Procyanidin A2, a polyphenolic compound, exerts anti-inflammatory and anti-oxidative activity in lipopolysaccharide-stimulated RAW264.7 cells. PLoS ONE. 2020; 15(8): e0237017.
Ibáñez B, Heusch G, Ovize M, Werf FVd. Evolving Therapies for Myocardial Ischemia/Reperfusion Injury. Journal of the American College of Cardiology. 2015; 65(14): 1454-1471.
Chen H, Tang LJ, Tu H, Zhou YJ, Peng J. Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis. European Journal of Pharmacology. 2020; 875: 1-12.
Vergely C, Maupoil V, Clermont G, Bril A, Rochette L. Identification and quantification of free radicals during myocardial ischemia and reperfusion using electron paramagnetic resonance spectroscopy. Archives of Biochemistry & Biophysics. 2003; 420(2): 209-216.
Tummers B, Green DR. Caspase‐8: regulating life and death. Immunological Reviews. 2017; 277(1): 76-89.
Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES. Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL. Journal of Biological Chemistry. 2013; 288(43): 31268-31279.
Machikas GA, Jackson MA, Hope KD. Inhibition of Programmed Necrosis Limits Infarct Size through Altered Mitochondrial and Immune Responses in the Aged Female Rat Heart. American Journal of Physiology Heart & Circulatory Physiology. 2018; 315(5): H1434-H1442.
Igor AE. ROS and RNS Signaling in Heart Disorders: Could Antioxidant Treatment Be Successful? Oxidative Medicine & Cellular Longevity. 2011; 2011(5): 1-14.
Kurian GA, Suryanarayanan S, Raman A, Padikkala J. Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts. Chinese Medicine. 2010; 5(1): 1-7.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Journal of Clinical Investigation. 2013; 123(1): 92-100.
Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, Wang J. Oxidative Stress in Cell Death and Cardiovascular Diseases. Oxidative medicine and cellular longevity. 2019; 2019: 1-12.
Milaeva ER. The role of radical reactions in organomercurials impact on lipid peroxidation. Journal of Inorganic Biochemistry. 2006; 99(5-6): 905-915.
Li XX, Zheng X, Liu Z, Xu Q, Tang H, Feng J, Yang S, Vong CT, Gao H, Wang Y. Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway. Chinese Medicine. 2020; 15: 1-13.
Gao S, Wang T, Huang XK, Jin Y, Wang J. Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats. Chinese Medicine. 2020; 15(1): 1-19.
Wei S, Zhangfeng Z, Kegang L, Wei X, Wing TAK, San CW, Hua Y, Yitao W. Siegesbeckia pubescens Makino inhibits Pam 3 CSK 4 -induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation. Chinese Medicine. 2018; 13(1): 1-10.
Kato T, Noma K, Ohara T, Kashima H, Fujiwara T. Cancer-Associated Fibroblasts Affect Intratumoral CD8 + and FoxP3 + T Cells via Interleukin 6 in the Tumor Microenvironment. Clinical Cancer Research. 2018; 24(19): 4820-4833.

Fig.S1.tif
The detection of cells’ morphological changes. H9c2 cells were pretreated with TI (1 μM) or nec-1 (100 μM）for 2 h, then exposed to t-BHP (150 μM) for 6 h, the cellular morphology was detected by microscope (Olympus, Tokyo , Japan).

Download PDF

Editorial decision: Major revision
19 May, 2021
Review #1 received at journal
22 Apr, 2021
Reviews received at journal
11 Apr, 2021
Reviewer #1 agreed at journal
11 Apr, 2021
Reviewers invited by journal
08 Apr, 2021
Editor assigned by journal
29 Mar, 2021
Submission checks completed at journal
29 Mar, 2021
Editor invited by journal
29 Mar, 2021
First submitted to journal
27 Mar, 2021

You are reading this latest preprint version

Tanshinone I Exerts Cardiovascular Protective Effects in Vivo and in Vitro Through Inhibiting Necroptosis via Akt/nrf2 Signaling Pathway

Status:

Version 1

Abstract

Figures

Background

Materials And Methods

Double staining assay

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Supplementary Files

Status:

Version 1